Knoll Capital Management, LLC

In its 13F for Q2 2026 (holdings as of June 30, 2026, filed September 10, 2026), Knoll Capital Management, LLC reported 37 stock positions worth $214.3 million. Its top holding was Biohaven Pharmaceutical Hold at 16.3% of the portfolio, followed by Meiragtx (MGTX, 7.9%) and Sprott Physical Gold Trust (PHYS, 5.4%). Compared with Q1 2026, it opened 1 new position, sold out of 1 and added to 5. The biggest buy was Biohaven Pharmaceutical Hold (shares +1%) and the biggest sale an exit from Cardiol Therapeutics Class A (CRDL).

Most Recent 13F
Q2 2026
Location
MIAMI, FL
CIK
0001325083
Portfolio Value
$214.3M (Q2 2026)
SEC Filing
0001104659-26-106457 ↗ filed Sep 10, 2026

Holdings Value

0$50.0M$100.0M$150.0M$200.0M$250.0M Q1 2024: $160.7M Q1 2024 Q2 2024: $148.4M Q2 2024 Q3 2024: $215.8M Q3 2024 Q4 2024: $155.3M Q4 2024 Q1 2025: $153.7M Q1 2025 Q2 2025: $140.7M Q2 2025 Q3 2025: $186.6M Q3 2025 Q4 2025: $218.0M Q4 2025 Q1 2026: $188.7M Q1 2026 Q2 2026: $214.3M $214.3M Q2 2026

Holdings 37 stocks · $214.3M
BIOHAVEN PHARMACEUTICAL HOLD 16.33% 2,352,520 $35.0M Add +1.0%
MGTX Meiragtx Holdings PLC 7.88% 1,250,000 $16.9M No change
PHYS Sprott Physical Gold Trust 5.45% 387,055 $11.7M No change
ALDX Aldeyra Therapeutics Inc. 5.44% 5,475,516 $11.7M No change
OCUL Ocular Therapeutix Inc. 5.27% 1,150,400 $11.3M Add +91.6%
RGLD Royal Gold Inc. 4.91% 52,750 $10.5M No change
ENTX Entera Bio Ltd. 4.86% 5,881,879 $10.4M No change
NUVB Nuvation Bio Inc. 4.24% 1,598,591 $9.1M Add +6.7%
AEM Agnico Eagle Mines Ltd. 3.82% 52,750 $8.2M No change
SA Seabridge Gold Inc. 3.81% 317,003 $8.2M No change
KGC Kinross Gold Corp. 3.53% 320,000 $7.6M No change
OR Or Royalties Inc. 3.32% 225,000 $7.1M No change
SSRM SSR Mining Inc. 3.23% 245,000 $6.9M No change
FNV Franco-Nevada Corp. 3.11% 32,000 $6.7M No change
BAH Booz Allen Hamilton Holdings 2.66% 13,000 $5.7M No change
CGAU Centerra Gold Inc. 2.66% 359,000 $5.7M No change
ELTX Elicio Therapeutics Inc. 2.21% 1,211,957 $4.7M Add +92.1%
ABVX Abivax SA-ADR 2.18% 35,000 $4.7M New
PAAS Pan American Silver Corp. 2.09% 100,035 $4.5M No change
PSLV Sprott Physical Silver Trust 1.96% 222,160 $4.2M No change
TFPM Triple Flag Precious Met 1.61% 115,000 $3.4M No change
ABEO Abeona Therapeutics Inc. 1.40% 485,515 $3.0M No change
GROY Gold Royalty Corp. 1.29% 1,000,000 $2.8M No change
NEWP New Pacific Metals Corp. 0.91% 485,000 $1.9M No change
ITA iShares U.S. Aerospace & Def 0.87% 7,650 $1.9M No change
PM Philip Morris International 0.84% 10,000 $1.8M No change
CDE Coeur Mining Inc. 0.73% 96,132 $1.6M No change
AGI Alamos Gold Inc. Class A 0.71% 50,000 $1.5M No change
WPM Wheaton Precious Metals Corp. 0.66% 12,500 $1.4M No change
NOC Northrop Grumman Corp. 0.51% 2,165 $1.1M No change
ELE Elemental Royalty Corp. 0.41% 50,000 $873K No change
VMET Versamet Royalties Corp. 0.38% 66,621 $821K No change
DC Dakota Gold Corp. 0.24% 122,921 $524K No change
AMRZ Amrize Ltd. 0.23% 9,175 $489K No change
ALT Altimmune Inc. 0.23% 160,000 $486K No change
PHAR Pharming Group NV - ADR 0.03% 4,091 $57K Add +0.8%
Orgenesis, Inc. 0.01% 50,623 $21K No change

Portfolio Sells Q1 2026 → Q2 2026
CRDL Cardiol Therapeutics Inc. Class A Sold out 0.00% −0.07

Portfolio Buys Q1 2026 → Q2 2026
BIOHAVEN PHARMACEUTICAL HOLD Add +1.0% 16.33% +5.89
OCUL Ocular Therapeutix Inc. Add +91.6% 5.27% +2.58
ABVX Abivax SA-ADR New 2.18% +2.18
NUVB Nuvation Bio Inc. Add +6.7% 4.24% +0.83
PHAR Pharming Group NV - ADR Add +0.8% 0.03% −0.01
ELTX Elicio Therapeutics Inc. Add +92.1% 2.21% −1.36

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q2 2026Amended 37$214.3MBIOHAVEN PHARMACEUTICAL HOLD, MGTX, PHYS, ALDX, OCUL
Q1 2026 37$188.7MBIOHAVEN PHARMACEUTICAL HOLD, PHYS, RGLD, MGTX, AEM
Q4 2025 33$218.0MALDX, BIOHAVEN PHARMACEUTICAL HOLD, NUVB, AVDL, GLD
Q3 2025 38$186.6MALDX, BIOHAVEN PHARMACEUTICAL HOLD, GLD, ENTX, MGTX
Q2 2025 38$140.7MALDX, BIOHAVEN PHARMACEUTICAL HOLD, ENTX, GLD, MGTX
Q1 2025 36$153.7MALDX, BIOHAVEN PHARMACEUTICAL HOLD, ENTX, GLD, MGTX
Q4 2024 35$155.3MBIOHAVEN PHARMACEUTICAL HOLD, ALDX, ENTX, VRNA, ALT
Q3 2024 36$215.8MAPLT, BIOHAVEN PHARMACEUTICAL HOLD, ALDX, AGI, AVDL
Q2 2024 35$148.4MAPLT, BIOHAVEN PHARMACEUTICAL HOLD, ALDX, AVDL, ALT
Q1 2024 34$160.7MAPLT, BIOHAVEN PHARMACEUTICAL HOLD, ALDX, AVDL, GLD